Literature DB >> 22564986

DNA methylation as a clinical marker in oncology.

Jean-Pierre Issa1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22564986     DOI： 10.1200/JCO.2012.42.1016

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  29 in total

1.  Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.

Authors:  Shanshan Zhao; Milan S Geybels; Amy Leonardson; Rohina Rubicz; Suzanne Kolb; Qingxiang Yan; Brandy Klotzle; Marina Bibikova; Antonio Hurtado-Coll; Dean Troyer; Raymond Lance; Daniel W Lin; Jonathan L Wright; Elaine A Ostrander; Jian-Bing Fan; Ziding Feng; Janet L Stanford
Journal:  Clin Cancer Res       Date:  2016-06-29       Impact factor: 12.531

2.  Abnormal hypermethylation and clinicopathological significance of Axin gene in lung cancer.

Authors:  Lian-He Yang; Hong-Tao Xu; Qing-Chang Li; Gui-Yang Jiang; Xiu-Peng Zhang; Huan-Yu Zhao; Ke Xu; En-Hua Wang
Journal:  Tumour Biol       Date:  2012-11-29

3.  DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.

Authors:  Gabriel G Malouf; Xiaoping Su; Jianping Zhang; Chad J Creighton; Thai H Ho; Yue Lu; Noël J-M Raynal; Jose A Karam; Pheroze Tamboli; Frederick Allanick; Roger Mouawad; Jean-Philippe Spano; David Khayat; Christopher G Wood; Jaroslav Jelinek; Nizar M Tannir
Journal:  Clin Cancer Res       Date:  2016-06-02       Impact factor: 12.531

4.  A METHYLATION-TO-EXPRESSION FEATURE MODEL FOR GENERATING ACCURATE PROGNOSTIC RISK SCORES AND IDENTIFYING DISEASE TARGETS IN CLEAR CELL KIDNEY CANCER.

Authors:  Jeffrey A Thompson; Carmen J Marsit
Journal:  Pac Symp Biocomput       Date:  2017

5.  ZNF695 methylation predicts a response of esophageal squamous cell carcinoma to definitive chemoradiotherapy.

Authors:  Takamasa Takahashi; Satoshi Yamahsita; Yasunori Matsuda; Takayoshi Kishino; Takeshi Nakajima; Ryoji Kushima; Ken Kato; Hiroyasu Igaki; Yuji Tachimori; Harushi Osugi; Masato Nagino; Toshikazu Ushijima
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-02       Impact factor: 4.553

Review 6.  Epigenetics and Precision Oncology.

Authors:  Rachael J Werner; Andrew D Kelly; Jean-Pierre J Issa
Journal:  Cancer J       Date:  2017 Sep/Oct       Impact factor: 3.360

7.  Introduction: Cancer as an Epigenetic Disease.

Authors:  Jean-Pierre J Issa
Journal:  Cancer J       Date:  2017 Sep/Oct       Impact factor: 3.360

8.  A novel prognostic six-CpG signature in glioblastomas.

Authors:  An-An Yin; Nan Lu; Amandine Etcheverry; Marc Aubry; Jill Barnholtz-Sloan; Lu-Hua Zhang; Jean Mosser; Wei Zhang; Xiang Zhang; Yu-He Liu; Ya-Long He
Journal:  CNS Neurosci Ther       Date:  2018-01-19       Impact factor: 5.243

9.  Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations.

Authors:  Austin K Mattox; Yuxuan Wang; Simeon Springer; Joshua D Cohen; Srinivasan Yegnasubramanian; William G Nelson; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-17       Impact factor: 11.205

10.  Validation of methylation biomarkers that distinguish normal colon mucosa of cancer patients from normal colon mucosa of patients without cancer.

Authors:  Matteo Cesaroni; Jasmine Powell; Carmen Sapienza
Journal:  Cancer Prev Res (Phila)       Date:  2014-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.